RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $169,000 | -64.1% | 17,455 | -33.7% | 0.01% | -73.0% |
| Q3 2021 | $471,000 | +40.2% | 26,321 | +91.4% | 0.04% | +32.1% |
| Q2 2021 | $336,000 | +232.7% | 13,749 | +3.2% | 0.03% | +154.5% |
| Q4 2020 | $101,000 | -44.5% | 13,323 | -63.4% | 0.01% | -8.3% |
| Q3 2020 | $182,000 | +2.8% | 36,363 | +22.7% | 0.01% | 0.0% |
| Q2 2020 | $177,000 | -33.0% | 29,642 | +6.9% | 0.01% | -25.0% |
| Q4 2019 | $264,000 | – | 27,739 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |